Back to Agendas
The Future of Clinical Trial Data Sharing
Session Chair(s)
Stephen P. Spielberg, MD, PhD
Editor-in-Chief
DIA, United States
The movement to enhance clinical trial transparency is a game changer for the industry. Recently, the Institute of Medicine (IOM) issued a report entitled Sharing Clinical Trial Data-Maximizing Benefits, Minimizing Risk that detailed guiding principles and a framework that included activities and strategies in sharing clinical trial data. Industry response has been positive as this could help reduce unnecessary data duplication, advance research and improve clinical care. But what are some of the barriers and roadblocks ahead, such as privacy and proprietary concerns or IT challenges (as an example) that may affect the future of clinical trial data sharing?
Submit your thoughts and questions to this distinguished panel by emailing annualmeetingprogram@diaglobal.org; subject The Future of Clinical Trial Data Sharing Q/A.
Learning Objective : Identify potential barriers to the sharing of clinical trial data; Describe how these barriers may affect the future of clinical trial data sharing.
Speaker(s)
Panelist
Joanne Waldstreicher, MD
Johnson & Johnson, United States
Chief Medical Officer
Panelist
Jarilyn Dupont, JD
FDA, United States
Director of Regulatory Policy, Office of Policy, OC
Panelist
David Eichmann, PhD
University of Iowa, United States
Director, Library Science & Info Science; Chair, Graduate Program Informatics
Panelist
Michael Rosenblatt, MD
Flagship Pioneering, United States
Chief Medical Officer
Panelist
Andrzej Rys, MD
European Commission, European Union, Belgium
Principal Scientific Advisor
Have an account?